| Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries |
49 |
| Update on management of diabetic foot ulcers |
46 |
| Inflammation in psychiatric disorders: what comes first? |
46 |
| Insulin regulation of gluconeogenesis |
44 |
| From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation |
42 |
| Regulatory T cells: a potential target in cancer immunotherapy |
38 |
| Land-atmospheric feedbacks during droughts and heatwaves: state of the science and current challenges |
35 |
| The neurobiology of interoception in health and disease |
32 |
| The Wnt signaling pathway: a potential therapeutic target against cancer |
30 |
| Impact of recent and future climate change on vector-borne diseases |
29 |
| Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries |
28 |
| Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs |
25 |
| The Arctic's sea ice cover: trends, variability, predictability, and comparisons to the Antarctic |
24 |
| The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics |
22 |
| Recent developments in understanding the role of the gut microbiota in brain health and disease |
22 |
| Disordered eating and obesity: associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities |
21 |
| Neural basis of bilingual language control |
21 |
| Phenotypic instability of chondrocytes in osteoarthritis: on a path to hypertrophy |
19 |
| Changing resource landscapes and spillover of henipaviruses |
18 |
| Major challenges for correlational ecological niche model projections to future climate conditions |
18 |
| Deciphering adipose tissue heterogeneity |
17 |
| Cardiometabolic risk in obese children |
17 |
| The increase in hemoglobin concentration with altitude varies among human populations |
17 |
| Axon initial segments: structure, function, and disease |
17 |
| Mechanisms of weight loss and improved metabolism following bariatric surgery |
16 |
| The role of the microbiome in nonhealing diabetic wounds |
16 |
| Myasthenia gravis with antibodies to MuSK: an update |
16 |
| Thymus involvement in early-onset myasthenia gravis |
15 |
| Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review |
14 |
| Statistical learning and probabilistic prediction in music cognition: mechanisms of stylistic enculturation |
14 |
| Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis |
14 |
| Indications and interpretation of esophageal function testing |
14 |
| Noncoding RNAs in ischemic stroke: time to translate |
13 |
| Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury |
13 |
| Evolutionary ecology of telomeres: a review |
13 |
| Neural mechanisms of social homeostasis |
13 |
| How attention gates social interactions |
13 |
| The effect of mindfulness meditation on sleep quality: a systematic review and meta-analysis of randomized controlled trials |
13 |
| Early life adversity and health-risk behaviors: proposed psychological and neural mechanisms |
13 |
| The neural basis of visual symmetry and its role in mid- and high-level visual processing |
12 |
| New pathogens, new tricks: emerging, drug-resistant fungal pathogens and future prospects for antifungal therapeutics |
12 |
| Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy |
12 |
| IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders |
12 |
| An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients |
12 |
| Conservation lessons from large-mammal manipulations in East African savannas: the KLEE, UHURU, and GLADE experiments |
12 |
| Circulating microRNAs as potential biomarkers in myasthenia gravis patients |
12 |
| Endoplasmic reticulum-mitochondria crosstalk: from junction to function across neurological disorders |
12 |
| Myasthenia gravis: the role of complement at the neuromuscular junction |
12 |
| Therapeutic strategies for congenital myasthenic syndromes |
12 |
| Complexities in understanding antimicrobial resistance across domesticated animal, human, and environmental systems |
12 |
